Variable endothelial cell function restoration after initiation of two antiretroviral regimens in HIV-infected individuals.

about

Nucleoside/nucleotide reverse transcriptase inhibitors attenuate angiogenesis and lymphangiogenesis by impairing receptor tyrosine kinases signalling in endothelial cells.Common Injuries and Repair Mechanisms in the Endothelial Lining

P2860

Q46130631-8E2CA860-0E47-4698-B710-5554121802D5 Q56979435-2687A337-375D-4BCA-82CE-B460629C0642

P2860

Variable endothelial cell function restoration after initiation of two antiretroviral regimens in HIV-infected individuals.

Item

http://www.wikidata.org/entity/Q40267454

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Variable endothelial cell func ...... s in HIV-infected individuals.

@en

type

Item

label

Variable endothelial cell func ...... s in HIV-infected individuals.

@en

prefLabel

Variable endothelial cell func ...... s in HIV-infected individuals.

@en

P1476

Variable endothelial cell func ...... s in HIV-infected individuals.

@en

P2093

A Bayés-Genís

http://www.w3.org/2001/XMLSchema#string

B Clotet

http://www.w3.org/2001/XMLSchema#string

E Gómez-Mora

http://www.w3.org/2001/XMLSchema#string

J Puig

http://www.w3.org/2001/XMLSchema#string

P Echeverría

http://www.w3.org/2001/XMLSchema#string

P2860

CD4+ count-guided interruption of antiretroviral treatment

Antiretrovirals induce endothelial dysfunction via an oxidant-dependent pathway and promote neointimal hyperplasia

Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation

Clinical and therapeutical implications of EPC biology in atherosclerosis.

Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s.

Roles and mechanisms of human immunodeficiency virus protease inhibitor ritonavir and other anti-human immunodeficiency virus drugs in endothelial dysfunction of porcine pulmonary arteries and human pulmonary artery endothelial cells.

Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis.

Pathogenesis of cardiovascular disease in HIV infection.

Vascular dysfunction in idiopathic dilated cardiomyopathy.

The challenges for cardiac vascular precursor cell therapy: lessons from a very elusive precursor.

P304

2049-2054

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JAC/DKX074

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-03-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28369542

http://www.w3.org/2001/XMLSchema#string

P921

endothelium

Variable endothelial cell function restoration after initiation of two antiretroviral regimens in HIV-infected individuals.

about

P2860

P2860

Variable endothelial cell function restoration after initiation of two antiretroviral regimens in HIV-infected individuals.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921